Project Grant HT9425261E055
Award Date 6/1/26
Completion Date 5/31/30
Dollars Obligated $2.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14203, USA
Similar Awards
- Federal Grant Award Summary Health Research, Inc. received a $958,389 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026, through May 31, 2030. As the Roswell Park Division of Health Research, the organization will conduct advanced biomedical research at its Buffalo, New York location. Based on the awardee's established portfolio, the research is expected to advance healthcare solutions...
- Federal Project Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $929,806 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports research focused on leveraging infiltrating myeloid cells to improve therapeutic response to bite-secreting T cells in ovarian cancer treatment. This research...
- This Project Grant award of $695,386.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Health Research, Inc. (Roswell Park Division) to investigate translation dysregulation in metastatic breast cancer. The project aims to evaluate the implications of this phenomenon for disease outcomes and immunotherapy responses. The award period runs from March 1, 2024 to February 28, 2027. As a prime grantee,...
- Federal Grant Award Summary Health Research, Inc., operating as Health Research At Roswell Park in Buffalo, New York, received a $173,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2027. The award supports research focused on improving chemotherapy efficacy for small cell carcinomas of the bladder, a rare cancer type with significant clinical relevance to military...
- Health Research, Inc., operating as Health Research At Roswell Park, received a $1,152,194 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research aimed at leveraging infiltrating myeloid cells to improve therapeutic response to bispecific T-cell engaging (BiTE) antibody-secreting T cells in ovarian cancer treatment. This four-year initiative...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,710,727.00 in funding to Health Research, Inc. (a non-profit organization) to conduct research on targeting the BRSK2 gene in aggressive breast cancer brain metastasis. The award period runs from Sep 30, 2024 to Sep 29, 2027. As a prime grantee, Health Research, Inc. will leverage its expertise in cancer biology, immunotherapy development, and biomarker...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.25 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026, through March 31, 2029. The project, titled "Unraveling Immunosuppressive Mechanisms in Breast Cancer Stem Cells for New Immunotherapy," involves research activities conducted at the institution's facility in Bronx, NY. This three-year award...
- Health Research, Inc. Roswell Park Division received a $559,647 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research using microfluidic lung cancer models. The two-year award, made on June 1, 2023 and set to conclude on May 31, 2025, will support investigating novel drug resistance mechanisms in lung cancer through "Microfluidic Lung Cancer On A Chip" models. As a past recipient of Defense...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1,249,920 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026 through March 31, 2029. The award supports research aimed at unraveling immunosuppressive mechanisms in breast cancer stem cells to identify new immunotherapy approaches. This three-year research initiative will be conducted at the institution's Bronx, New York...